Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
216
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Ramadan and Diabetes: What About Non-Fasting Patients with Diabetes?

Imane Motaib1 Department of Endocrinology, Diabetology, Metabolic Disease, and Nutrition, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MoroccoCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-8426-3929
ORCID Icon,
Fatima-Zahra Rhmari Tlemçani1 Department of Endocrinology, Diabetology, Metabolic Disease, and Nutrition, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MoroccoORCID Iconhttps://orcid.org/0000-0002-1450-458X
ORCID Icon,
Mohamed Khalis2 International School of Public Health, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MoroccoORCID Iconhttps://orcid.org/0000-0003-4639-049X
ORCID Icon,
Soukaina Laidi1 Department of Endocrinology, Diabetology, Metabolic Disease, and Nutrition, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco
,
Saloua Elamari1 Department of Endocrinology, Diabetology, Metabolic Disease, and Nutrition, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MoroccoORCID Iconhttps://orcid.org/0000-0003-3039-0137
ORCID Icon &
Asma Chadli1 Department of Endocrinology, Diabetology, Metabolic Disease, and Nutrition, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco
Pages 1975-1983 | Published online: 28 Jun 2022

References

  • Zaghlol LY, Beirat AF, Amarin JZ, et al. Effect of dosage reduction of hypoglycemic multidrug regimens on the incidences of acute glycemic complications in people with type 2 diabetes who fast during Ramaḍān: a randomized controlled trial. Front Endocrinol. 2021;12:613826. doi:10.3389/fendo.2021.613826
  • Jabbar A, Hassanein M, Beshyah SA, Boye KS, Yu M, Babineaux SM. CREED study: hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents. Diabetes Res Clin Pract. 2017;132:19–26. doi:10.1016/j.diabres.2017.07.014
  • Salti I, Bénard E, Detournay B, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306–2311. doi:10.2337/diacare.27.10.2306
  • IDF-DAR-practical-guidelines_15-April-2016_low_SA.pdf. Available from: https://www.daralliance.org/daralliance/wp-content/uploads/2018/01/IDF-DAR-Practical-Guidelines_15-April-2016_low_SA.pdf. Accessed December 10, 2021.
  • Sebbani M, Mghari G, Amine M, Amine M. Apports alimentaires durant le mois de ramadan chez le patient diabétique de type 2 marocain[Food intake during the month of Ramadan in Moroccan patients with type 2 diabetes]. East Mediterr Health J. 2013;19:276–281. French. doi:10.26719/2013.19.3.276
  • Barakat I, Chamlal H, El Jamal S, Elayachi M, Belahsen R, S. Razzaque M. Food expenditure and food consumption before and during Ramadan in Moroccan households. J Nutr Metab. 2020;2020:8849832. doi:10.1155/2020/8849832
  • Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Human Kinetics Books; 1988.
  • Consultation WH. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii, 1–253.
  • NGSP: HbA1c assay interferences. Available from: http://www.ngsp.org/interf.asp. Accessed December 10, 2021.
  • Martin SS, Blaha MJ, Elshazly MB, et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013;310(19):2061–2068. doi:10.1001/jama.2013.280532
  • Cleeman J. ATP III guidelines At-A-glance quick desk reference; 2001:6.
  • Association AD. 10. cardiovascular disease and risk management: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement1):S125–S150. doi:10.2337/dc21-S010
  • El Kinany K, Garcia-Larsen V, Khalis M, et al. Adaptation and validation of a food frequency questionnaire (FFQ) to assess dietary intake in Moroccan adults. Nutr J. 2018;17(1):61. doi:10.1186/s12937-018-0368-4
  • GPAQ_FR.pdf. Available from: https://www.who.int/ncds/surveillance/steps/GPAQ_FR.pdf. Accessed December 10, 2021.
  • Bahijri S, Borai A, Ajabnoor G, et al. Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan. PLoS One. 2013;8(4):e60917. doi:10.1371/journal.pone.0060917
  • Jauch-Chara K, Hallschmid M, Schmid SM, et al. Plasma glucagon decreases during night-time sleep in Type 1 diabetic patients and healthy control subjects. Diabet Med. 2007;24(6):684–687. doi:10.1111/j.1464-5491.2007.02116.x
  • Ajabnoor GM, Bahijri S, Borai A, Abdulkhaliq AA, Al-Aama JY, Chrousos GP. Health impact of fasting in Saudi Arabia during Ramadan: association with disturbed circadian rhythm and metabolic and sleeping patterns. PLoS One. 2014;9(5):e96500. doi:10.1371/journal.pone.0096500
  • Kermansaravi M, Omar I, Mahawar K, et al. Religious fasting of Muslim patients after metabolic and bariatric surgery: a modified delphi consensus. Obes Surg. 2021;31(12):5303–5311. doi:10.1007/s11695-021-05724-z
  • International Diabetes Federation and DAR International Alliance. Diabetes and Ramadan: practical guidelines, Brussels, Belgium: International Diabetes Federation; 2021. Available from: www.idf.org/guidelines/diabetes-in-ramadan. Accessed April 8, 2021.
  • Tahapary DL, Astrella C, Kristanti M, Harbuwono DS, Soewondo P. The impact of Ramadan fasting on metabolic profile among type 2 diabetes mellitus patients: a meta-analysis. Diabetes Metab Syndr. 2020;14(5):1559–1570. doi:10.1016/j.dsx.2020.07.033
  • Srivastava RAK. Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. J Diabetes Metab Disord. 2018;17(2):381–391. doi:10.1007/s40200-018-0378-y

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.